Maiden AIDS vaccine could soon be a reality
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2014
Singapore: At the AIDS 2014 Conference in Melbourne, Australia, scientists declared that they had identified a biomarker...Read more
Patrys released myeloma trial data
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2013
Singapore: Patrys released additional data from the first cohort of multiple myeloma patients treated with PAT-SM6 in th...Read more
Linear Clinical Research wins Emerging Exporter Award
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Australian company Linear Clinical Research has won the Emerging Exporter of the year Award at the 50th annua...Read more
Clinuvel starts US phase III trial of SCENESSE
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 May, 2012
Singapore: Clinuvel Pharmaceuticals commenced its confirmatory phase III clinical trial of its novel drug SCENESSE (afam...Read more
Phylogica looks for tie-ups in Asia: COO Nick Woolf
Australia | Influencers | By BioSpectrum Bureau | 3 Comment | 15 May, 2012
Phylogica, a leading peptide drug discovery company based in Australia, has developed a world-class drug discovery platf...Read more
FDA end-of-phase II for head lice product
Australia | Regulatory | By BioSpectrum Bureau | 1 Comment | 06 Sep, 2012
Singapore: Specialty pharmaceutical company Hatchtech successfully completed end-of-phase II (EOP2) consultations with t...Read more
Senz starts phase II cancer trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2012
Singapore: Senz Oncology announced that the ï¬rst patient has commenced treatment in a phase I/II clinical evaluati...Read more
Resverlogix initiates phase II diabetes trials
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2012
Singapore: Resverlogix has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to e...Read more
LSQ: Financial crunch makes capital harder to get
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2013
Life Sciences Queensland (LSQ), Australia, offers opportunity for industry stakeholders to come together and cooperate t...Read more
APAC's NSCLC market to show robust growth by 2019
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2014
Singapore: The GBI Research has revealed that the non-small cell lung cancer (NSCLC) therapeutics market value in the As...Read more
Which domain of clinical research do APAC CROs focus on?
Australia | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
Charles Walker is Alchemia's new CEO
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Feb, 2013
Singapore: Brisbane-based pharma firm Alchemia has appointed Mr Charles (Charlie) Walker as its chief executive officer....Read more
Patrys begins multiple myeloma trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2012
Singapore: Patrys, an Australian clinical stage biopharmaceutical company, has completed the initial treatment of the fi...Read more
Scientists make eye lens from stem cells in petri dish
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2013
Singapore: Associate Professor Tiziano Barberi and Dr Isabella Mengarelli from the Australian Regenerative Medicine Inst...Read more
Echo Therapeutics expands agreement with Ferndale
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2012
Singapore: US-based Echo Therapeutics, a company developing its needle-free Symphony tCGM System as a non-invasive, wire...Read more
Aussie firm begins prostate cancer screening test in US
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2014
Singapore: Australian biotechnology company Minomic is all set to launch two overseas trials of its MiStat prostate canc...Read more
Accenture: Health records result in reduced medical error
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2013
Singapore: According to a survey by Accenture, majority of Australian doctors (77 percent) have highlighted that sharing...Read more
Marc Wolff is CFO of ReSearch Pharma Services
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
‎Singapore: ReSearch Pharmaceutical Services, a clinical research firm, has appointed Mr Marc Wolff as its chief f...Read more